Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Oct 15;375(Pt 2):373–383. doi: 10.1042/BJ20030689

Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system.

Latif A Wafa 1, Helen Cheng 1, Mira A Rao 1, Colleen C Nelson 1, Michael Cox 1, Martin Hirst 1, Ivan Sadowski 1, Paul S Rennie 1
PMCID: PMC1223690  PMID: 12864730

Abstract

The AR (androgen receptor) is a ligand-regulated transcription factor, which belongs to the steroid receptor family and plays an essential role in growth and development of the prostate. Transcriptional activity of steroid receptors is modulated by interaction with co-regulator proteins and yeast two-hybrid analysis is commonly used to identify these steroid receptor-interacting proteins. However, a limitation of conventional two-hybrid systems for detecting AR protein partners has been that they only allow for analysis of the ligand- and DNA-binding domains of the receptor, as its NTD (N-terminal domain) possesses intrinsic transactivation activity. To identify AR N-terminus-interacting proteins, its NTD was used in the RTA (repressed transactivator) system, which is specifically designed for transactivator bait proteins and was shown to be suitable for two-hybrid analysis with the AR NTD. DDC (L-dopa decarboxylase) was detected multiple times as a novel AR-interacting protein, which was subsequently confirmed in vitro and in vivo. Furthermore, transient transfection of DDC in prostate cancer cells strongly enhanced ligand-dependent AR transcriptional activity, an effect that was antagonized using high concentrations of the anti-androgen bicalutamide. Glucocorticoid receptor activity was also strongly enhanced with DDC co-transfection, while oestrogen receptor activity was only mildly affected. Together, our data demonstrate that DDC interacts with AR to enhance steroid receptor transactivation, which may have important implications in prostate cancer progression.

Full Text

The Full Text of this article is available as a PDF (284.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apostolakis E. M., Garai J., Fox C., Smith C. L., Watson S. J., Clark J. H., O'Malley B. W. Dopaminergic regulation of progesterone receptors: brain D5 dopamine receptors mediate induction of lordosis by D1-like agonists in rats. J Neurosci. 1996 Aug 15;16(16):4823–4834. doi: 10.1523/JNEUROSCI.16-16-04823.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beato M., Chávez S., Truss M. Transcriptional regulation by steroid hormones. Steroids. 1996 Apr;61(4):240–251. doi: 10.1016/0039-128x(96)00030-x. [DOI] [PubMed] [Google Scholar]
  3. Berry M. D., Juorio A. V., Li X. M., Boulton A. A. Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme. Neurochem Res. 1996 Sep;21(9):1075–1087. doi: 10.1007/BF02532418. [DOI] [PubMed] [Google Scholar]
  4. Bevan C. L., Hoare S., Claessens F., Heery D. M., Parker M. G. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol. 1999 Dec;19(12):8383–8392. doi: 10.1128/mcb.19.12.8383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boeke J. D., Trueheart J., Natsoulis G., Fink G. R. 5-Fluoroorotic acid as a selective agent in yeast molecular genetics. Methods Enzymol. 1987;154:164–175. doi: 10.1016/0076-6879(87)54076-9. [DOI] [PubMed] [Google Scholar]
  6. Cohen R. J., Glezerson G., Haffejee Z. Neuro-endocrine cells--a new prognostic parameter in prostate cancer. Br J Urol. 1991 Sep;68(3):258–262. doi: 10.1111/j.1464-410x.1991.tb15318.x. [DOI] [PubMed] [Google Scholar]
  7. Fang Y., Fliss A. E., Robins D. M., Caplan A. J. Hsp90 regulates androgen receptor hormone binding affinity in vivo. J Biol Chem. 1996 Nov 8;271(45):28697–28702. doi: 10.1074/jbc.271.45.28697. [DOI] [PubMed] [Google Scholar]
  8. Froesch B. A., Takayama S., Reed J. C. BAG-1L protein enhances androgen receptor function. J Biol Chem. 1998 May 8;273(19):11660–11666. doi: 10.1074/jbc.273.19.11660. [DOI] [PubMed] [Google Scholar]
  9. Frønsdal K., Engedal N., Slagsvold T., Saatcioglu F. CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1. J Biol Chem. 1998 Nov 27;273(48):31853–31859. doi: 10.1074/jbc.273.48.31853. [DOI] [PubMed] [Google Scholar]
  10. Gazdar A. F., Helman L. J., Israel M. A., Russell E. K., Linnoila R. I., Mulshine J. L., Schuller H. M., Park J. G. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res. 1988 Jul 15;48(14):4078–4082. [PubMed] [Google Scholar]
  11. Green S., Chambon P. Nuclear receptors enhance our understanding of transcription regulation. Trends Genet. 1988 Nov;4(11):309–314. doi: 10.1016/0168-9525(88)90108-4. [DOI] [PubMed] [Google Scholar]
  12. Greene G. L., Press M. F. Structure and dynamics of the estrogen receptor. J Steroid Biochem. 1986 Jan;24(1):1–7. doi: 10.1016/0022-4731(86)90024-5. [DOI] [PubMed] [Google Scholar]
  13. He B., Kemppainen J. A., Voegel J. J., Gronemeyer H., Wilson E. M. Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain. J Biol Chem. 1999 Dec 24;274(52):37219–37225. doi: 10.1074/jbc.274.52.37219. [DOI] [PubMed] [Google Scholar]
  14. Hirst M., Ho C., Sabourin L., Rudnicki M., Penn L., Sadowski I. A two-hybrid system for transactivator bait proteins. Proc Natl Acad Sci U S A. 2001 Jul 10;98(15):8726–8731. doi: 10.1073/pnas.141413598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hittelman A. B., Burakov D., Iñiguez-Lluhí J. A., Freedman L. P., Garabedian M. J. Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J. 1999 Oct 1;18(19):5380–5388. doi: 10.1093/emboj/18.19.5380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Horwitz K. B., Jackson T. A., Bain D. L., Richer J. K., Takimoto G. S., Tung L. Nuclear receptor coactivators and corepressors. Mol Endocrinol. 1996 Oct;10(10):1167–1177. doi: 10.1210/mend.10.10.9121485. [DOI] [PubMed] [Google Scholar]
  17. Hu Yan, Ippolito Joseph E., Garabedian Emily M., Humphrey Peter A., Gordon Jeffrey I. Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice. J Biol Chem. 2002 Sep 11;277(46):44462–44474. doi: 10.1074/jbc.M205784200. [DOI] [PubMed] [Google Scholar]
  18. Ichinose H., Kurosawa Y., Titani K., Fujita K., Nagatsu T. Isolation and characterization of a cDNA clone encoding human aromatic L-amino acid decarboxylase. Biochem Biophys Res Commun. 1989 Nov 15;164(3):1024–1030. doi: 10.1016/0006-291x(89)91772-5. [DOI] [PubMed] [Google Scholar]
  19. Ichinose H., Sumi-Ichinose C., Ohye T., Hagino Y., Fujita K., Nagatsu T. Tissue-specific alternative splicing of the first exon generates two types of mRNAs in human aromatic L-amino acid decarboxylase. Biochemistry. 1992 Nov 24;31(46):11546–11550. doi: 10.1021/bi00161a036. [DOI] [PubMed] [Google Scholar]
  20. Ikonen T., Palvimo J. J., Jänne O. A. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem. 1997 Nov 21;272(47):29821–29828. doi: 10.1074/jbc.272.47.29821. [DOI] [PubMed] [Google Scholar]
  21. Jenster G., van der Korput H. A., Trapman J., Brinkmann A. O. Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem. 1995 Mar 31;270(13):7341–7346. doi: 10.1074/jbc.270.13.7341. [DOI] [PubMed] [Google Scholar]
  22. Jongsma J., Oomen M. H., Noordzij M. A., Romijn J. C., van Der Kwast T. H., Schröder F. H., van Steenbrugge G. J. Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines. Prostate. 2000 Jan;42(1):34–44. doi: 10.1002/(sici)1097-0045(20000101)42:1<34::aid-pros5>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  23. Kanaoka Y., Kimura S. H., Okazaki I., Ikeda M., Nojima H. GAK: a cyclin G associated kinase contains a tensin/auxilin-like domain. FEBS Lett. 1997 Jan 27;402(1):73–80. doi: 10.1016/s0014-5793(96)01484-6. [DOI] [PubMed] [Google Scholar]
  24. Kuil C. W., Berrevoets C. A., Mulder E. Ligand-induced conformational alterations of the androgen receptor analyzed by limited trypsinization. Studies on the mechanism of antiandrogen action. J Biol Chem. 1995 Nov 17;270(46):27569–27576. doi: 10.1074/jbc.270.46.27569. [DOI] [PubMed] [Google Scholar]
  25. Lu M. L., Schneider M. C., Zheng Y., Zhang X., Richie J. P. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem. 2001 Jan 18;276(16):13442–13451. doi: 10.1074/jbc.M006598200. [DOI] [PubMed] [Google Scholar]
  26. Mani S. K., Allen J. M., Clark J. H., Blaustein J. D., O'Malley B. W. Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior. Science. 1994 Aug 26;265(5176):1246–1249. doi: 10.1126/science.7915049. [DOI] [PubMed] [Google Scholar]
  27. Markus Steven M., Taneja Samir S., Logan Susan K., Li Wenhui, Ha Susan, Hittelman Adam B., Rogatsky Inez, Garabedian Michael J. Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus. Mol Biol Cell. 2002 Feb;13(2):670–682. doi: 10.1091/mbc.01-10-0513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. McEwan I. J., Gustafsson J. Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8485–8490. doi: 10.1073/pnas.94.16.8485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Miesfeld R., Rusconi S., Godowski P. J., Maler B. A., Okret S., Wikström A. C., Gustafsson J. A., Yamamoto K. R. Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell. 1986 Aug 1;46(3):389–399. doi: 10.1016/0092-8674(86)90659-8. [DOI] [PubMed] [Google Scholar]
  30. Moilanen A. M., Karvonen U., Poukka H., Yan W., Toppari J., Jänne O. A., Palvimo J. J. A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins. J Biol Chem. 1999 Feb 5;274(6):3700–3704. doi: 10.1074/jbc.274.6.3700. [DOI] [PubMed] [Google Scholar]
  31. Nelson C. C., Hendy S. C., Shukin R. J., Cheng H., Bruchovsky N., Koop B. F., Rennie P. S. Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements. Mol Endocrinol. 1999 Dec;13(12):2090–2107. doi: 10.1210/mend.13.12.0396. [DOI] [PubMed] [Google Scholar]
  32. Nelson Peter S., Clegg Nigel, Arnold Hugh, Ferguson Camari, Bonham Michael, White James, Hood Leroy, Lin Biaoyang. The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci U S A. 2002 Aug 16;99(18):11890–11895. doi: 10.1073/pnas.182376299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ozanne D. M., Brady M. E., Cook S., Gaughan L., Neal D. E., Robson C. N. Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin. Mol Endocrinol. 2000 Oct;14(10):1618–1626. doi: 10.1210/mend.14.10.0541. [DOI] [PubMed] [Google Scholar]
  34. Petre Christin E., Wetherill Yelena B., Danielsen Mark, Knudsen Karen E. Cyclin D1: mechanism and consequence of androgen receptor co-repressor activity. J Biol Chem. 2001 Nov 19;277(3):2207–2215. doi: 10.1074/jbc.M106399200. [DOI] [PubMed] [Google Scholar]
  35. Poulikakos P., Vassilacopoulou D., Fragoulis E. G. L-DOPA decarboxylase association with membranes in mouse brain. Neurochem Res. 2001 May;26(5):479–485. doi: 10.1023/a:1010952610387. [DOI] [PubMed] [Google Scholar]
  36. Rao Mira A., Cheng Helen, Quayle Alandra N., Nishitani Hideo, Nelson Colleen C., Rennie Paul S. RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor. J Biol Chem. 2002 Oct 1;277(50):48020–48027. doi: 10.1074/jbc.M209741200. [DOI] [PubMed] [Google Scholar]
  37. Rennie P. S., Bruchovsky N., Leco K. J., Sheppard P. C., McQueen S. A., Cheng H., Snoek R., Hamel A., Bock M. E., MacDonald B. S. Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol Endocrinol. 1993 Jan;7(1):23–36. doi: 10.1210/mend.7.1.8446105. [DOI] [PubMed] [Google Scholar]
  38. Sato N., Sadar M. D., Bruchovsky N., Saatcioglu F., Rennie P. S., Sato S., Lange P. H., Gleave M. E. Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP. J Biol Chem. 1997 Jul 11;272(28):17485–17494. doi: 10.1074/jbc.272.28.17485. [DOI] [PubMed] [Google Scholar]
  39. Smith C. L., Conneely O. M., O'Malley B. W. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6120–6124. doi: 10.1073/pnas.90.13.6120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Snoek R., Rennie P. S., Kasper S., Matusik R. J., Bruchovsky N. Induction of cell-free, in vitro transcription by recombinant androgen receptor peptides. J Steroid Biochem Mol Biol. 1996 Nov;59(3-4):243–250. doi: 10.1016/s0960-0760(96)00116-1. [DOI] [PubMed] [Google Scholar]
  41. Ting Huei-Ju, Yeh Shuyuan, Nishimura Kazuo, Chang Chawnshang. Supervillin associates with androgen receptor and modulates its transcriptional activity. Proc Natl Acad Sci U S A. 2002 Jan 15;99(2):661–666. doi: 10.1073/pnas.022469899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Truica C. I., Byers S., Gelmann E. P. Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res. 2000 Sep 1;60(17):4709–4713. [PubMed] [Google Scholar]
  43. Tzamarias D., Struhl K. Functional dissection of the yeast Cyc8-Tup1 transcriptional co-repressor complex. Nature. 1994 Jun 30;369(6483):758–761. doi: 10.1038/369758a0. [DOI] [PubMed] [Google Scholar]
  44. Ueda Takeshi, Bruchovsky Nicholas, Sadar Marianne D. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J Biol Chem. 2001 Dec 19;277(9):7076–7085. doi: 10.1074/jbc.M108255200. [DOI] [PubMed] [Google Scholar]
  45. Veldscholte J., Berrevoets C. A., Brinkmann A. O., Grootegoed J. A., Mulder E. Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation. Biochemistry. 1992 Mar 3;31(8):2393–2399. doi: 10.1021/bi00123a026. [DOI] [PubMed] [Google Scholar]
  46. Veldscholte J., Ris-Stalpers C., Kuiper G. G., Jenster G., Berrevoets C., Claassen E., van Rooij H. C., Trapman J., Brinkmann A. O., Mulder E. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun. 1990 Dec 14;173(2):534–540. doi: 10.1016/s0006-291x(05)80067-1. [DOI] [PubMed] [Google Scholar]
  47. Vidal M., Brachmann R. K., Fattaey A., Harlow E., Boeke J. D. Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10315–10320. doi: 10.1073/pnas.93.19.10315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Watanabe H., Imaizumi M., Ojika T., Abe T., Hida T., Kato K. Evaluation of biological characteristics of lung cancer by the human 28 kDa vitamin D-dependent calcium binding protein, calbindin-D28k. Jpn J Clin Oncol. 1994 Jun;24(3):121–127. [PubMed] [Google Scholar]
  49. Yeh S., Chang C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci U S A. 1996 May 28;93(11):5517–5521. doi: 10.1073/pnas.93.11.5517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Zhao Yue, Goto Kiminobu, Saitoh Masayuki, Yanase Toshihiko, Nomura Masatoshi, Okabe Taijiro, Takayanagi Ryoichi, Nawata Hajime. Activation function-1 domain of androgen receptor contributes to the interaction between subnuclear splicing factor compartment and nuclear receptor compartment. Identification of the p102 U5 small nuclear ribonucleoprotein particle-binding protein as a coactivator for the receptor. J Biol Chem. 2002 May 30;277(33):30031–30039. doi: 10.1074/jbc.M203811200. [DOI] [PubMed] [Google Scholar]
  51. Zhu M. Y., Juorio A. V. Aromatic L-amino acid decarboxylase: biological characterization and functional role. Gen Pharmacol. 1995 Jul;26(4):681–696. doi: 10.1016/0306-3623(94)00223-a. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES